Trademark: 90451256
Word
BELLA HEALTH
Status
Pending
Status Code
630
Status Date
Saturday, January 9, 2021
Serial Number
90451256
Mark Type
4000
Filing Date
Wednesday, January 6, 2021

Trademark Owner History

Classifications
5 Diagnostic kits comprised of medical diagnostic assays for use in disease detection, screening, treating and monitoring, namely, monitoring COVID-19 and other infectious diseases; Respiratory rapid tests, namely, assays for use in performing respiratory rapid tests related to COVID-19 and other infectious diseases; Screening tests and devices to detect COVID-19 and other infectious diseases in a patient
9 Downloadable computer application software for mobile phones, namely, software for covid-19 and other infectious disease identification; Downloadable computer application software for computers, namely, software for covid-19 and other infectious disease identification; Downloadable mobile applications for health screenings relating to COVID-19 and other infectious disease; Downloadable mobile applications for tracking and reporting health conditions and symptoms
42 Providing temporary use of online non-downloadable software for use in the testing and diagnosis of COVID-19, coronavirus, and other diseases; Scientific apparatus and instruments, namely, COVID-19 rapid tests for withdrawing and testing respiratory droplets for clinical, medical, research, and scientific purposes and parts and fittings thereof; Material testing apparatus and instruments, for identifying and testing pathogens and biomarkers in respiratory droplets for clinical, medical, research, and scientific purposes related to COVID-19 and other infectious diseases; Apparatus for transmission of communication; Monitoring, measuring, signaling and control apparatus and instruments for testing respiratory droplets against a panel of biomarkers for clinical, medical, research, and scientific purposes, namely, for COVID-19 and other infectious diseases; Providing temporary use of online non-downloadable software for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms; Providing temporary use of web-based software applications for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms; Software as a service (SAAS) services featuring software for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms
44 Healthcare services; Medical and healthcare information, consultancy and advisory services relating to infections, viruses, SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Providing a web site featuring medical information; Health care services, namely, disease management programs; Telehealth services, namely, providing telemedicine and services in conjunction with providing medical and healthcare services; Information collection and management services in the field of public health, namely, collecting, verifying, tracing, tracking, storing, monitoring, and notifying physical sites visited by persons infected with contagious disease for the purpose of slowing or stopping the spread of the disease under the guidance of state and local public health departments; Information collection and management services in the field of public health, namely, collecting, verifying, tracing, tracking, storing, monitoring, and notifying contacts of persons infected with contagious disease for the purpose of slowing or stopping the spread of the disease under the guidance of state and local public health departments; Mobile healthcare services in the field of Covid and other infectious disease testing, health assessments, intravenous infusion therapy, facilitating appointments

Trademark Events
Jan 9, 2021
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2021-01-13